Cabot Co. (NYSE:CBT) Shares Bought by Livforsakringsbolaget Skandia Omsesidigt

Livforsakringsbolaget Skandia Omsesidigt raised its position in Cabot Co. (NYSE:CBT - Free Report) by 260.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,400 shares of the specialty chemicals company's stock after purchasing an additional 10,400 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt's holdings in Cabot were worth $1,315,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. First Citizens Bank & Trust Co. lifted its stake in Cabot by 2.1% during the third quarter. First Citizens Bank & Trust Co. now owns 5,426 shares of the specialty chemicals company's stock worth $606,000 after purchasing an additional 109 shares in the last quarter. First Horizon Advisors Inc. grew its holdings in Cabot by 22.0% during the 3rd quarter. First Horizon Advisors Inc. now owns 650 shares of the specialty chemicals company's stock worth $73,000 after acquiring an additional 117 shares in the last quarter. UMB Bank n.a. boosted its position in shares of Cabot by 53.9% during the 3rd quarter. UMB Bank n.a. now owns 371 shares of the specialty chemicals company's stock worth $41,000 after acquiring an additional 130 shares in the last quarter. GAMMA Investing LLC increased its stake in Cabot by 10.7% in the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock valued at $123,000 after purchasing an additional 130 shares during the last quarter. Finally, CWM LLC raised its stake in Cabot by 35.6% during the 3rd quarter. CWM LLC now owns 564 shares of the specialty chemicals company's stock worth $63,000 after acquiring an additional 148 shares in the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on CBT. Mizuho decreased their price target on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating for the company in a research note on Tuesday, January 7th. JPMorgan Chase & Co. lowered Cabot from a "neutral" rating to an "underweight" rating and set a $105.00 price target on the stock. in a report on Monday, November 11th. Finally, StockNews.com downgraded Cabot from a "buy" rating to a "hold" rating in a research note on Monday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, Cabot currently has an average rating of "Hold" and a consensus price target of $102.00.

Insider Buying and Selling at Cabot

In other Cabot news, EVP Jeff Ji Zhu sold 14,566 shares of the stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $113.25, for a total value of $1,649,599.50. Following the completion of the transaction, the executive vice president now directly owns 69,449 shares of the company's stock, valued at approximately $7,865,099.25. This trade represents a 17.34 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CAO Lisa M. Dumont sold 865 shares of Cabot stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $111.74, for a total transaction of $96,655.10. Following the sale, the chief accounting officer now owns 9,742 shares of the company's stock, valued at approximately $1,088,571.08. The trade was a 8.15 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.03% of the stock is owned by corporate insiders.

Cabot Stock Performance

Shares of NYSE:CBT traded down $0.33 during midday trading on Tuesday, hitting $86.00. The stock had a trading volume of 424,556 shares, compared to its average volume of 385,884. The company has a market capitalization of $4.66 billion, a PE ratio of 11.42, a P/E/G ratio of 0.76 and a beta of 1.19. Cabot Co. has a 1 year low of $78.61 and a 1 year high of $117.46. The stock has a 50 day moving average price of $92.47 and a two-hundred day moving average price of $101.62. The company has a current ratio of 2.00, a quick ratio of 1.36 and a debt-to-equity ratio of 0.72.

Cabot (NYSE:CBT - Get Free Report) last released its earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. As a group, equities analysts predict that Cabot Co. will post 7.57 earnings per share for the current fiscal year.

Cabot Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be given a $0.43 dividend. This represents a $1.72 annualized dividend and a yield of 2.00%. The ex-dividend date of this dividend is Friday, February 28th. Cabot's payout ratio is 22.84%.

Cabot declared that its Board of Directors has initiated a stock repurchase program on Tuesday, December 3rd that permits the company to buyback 10,000,000 shares. This buyback authorization permits the specialty chemicals company to purchase shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company's board believes its stock is undervalued.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.